Patent · US Expired

IGF-1 receptor interacting proteins

US7202058B2 · kind B2 · utility

0Cited by

2References

1Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Tanja Ligensa · Lohmar, DE
Ralf Schumacher · Penzberg, DE
Michael Weidner · Sunrise, US

Key dates

Filing date	Jun 14, 2004
Grant date	Apr 10, 2007
Priority date	—
Expiry date	Jun 14, 2024

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention comprises a method of screening compound(s) that inhibit the interaction between IGF-1R and IIP-10.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.